Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Interaction with the DNA Repair Protein Thymine DNA Glycosylase Regulates Histone Acetylation by p300.

Henry RA, Mancuso P, Kuo YM, Tricarico R, Tini M, Cole PA, Bellacosa A, Andrews AJ.

Biochemistry. 2016 Dec 13;55(49):6766-6775.

2.

Protein lysine acetylation by p300/CBP.

Dancy BM, Cole PA.

Chem Rev. 2015 Mar 25;115(6):2419-52. doi: 10.1021/cr500452k. Review. No abstract available. Erratum in: Chem Rev. 2016 Jul 27;116(14 ):8314.

3.

Amplified in breast cancer 1 promotes colorectal cancer progression through enhancing notch signaling.

Mo P, Zhou Q, Guan L, Wang Y, Wang W, Miao M, Tong Z, Li M, Majaz S, Liu Y, Su G, Xu J, Yu C.

Oncogene. 2015 Jul 23;34(30):3935-45. doi: 10.1038/onc.2014.324.

4.

Vascular histone deacetylation by pharmacological HDAC inhibition.

Rafehi H, Balcerczyk A, Lunke S, Kaspi A, Ziemann M, Kn H, Okabe J, Khurana I, Ooi J, Khan AW, Du XJ, Chang L, Haviv I, Keating ST, Karagiannis TC, El-Osta A.

Genome Res. 2014 Aug;24(8):1271-84. doi: 10.1101/gr.168781.113.

5.

Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.

Das C, Roy S, Namjoshi S, Malarkey CS, Jones DN, Kutateladze TG, Churchill ME, Tyler JK.

Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):E1072-81. doi: 10.1073/pnas.1319122111.

6.

DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.

Lin S, Tian L, Shen H, Gu Y, Li JL, Chen Z, Sun X, You MJ, Wu L.

Oncogene. 2013 Oct;32(40):4845-53. doi: 10.1038/onc.2012.482.

7.

MAML1 acts cooperatively with EGR1 to activate EGR1-regulated promoters: implications for nephrogenesis and the development of renal cancer.

Hansson ML, Behmer S, Ceder R, Mohammadi S, Preta G, Grafström RC, Fadeel B, Wallberg AE.

PLoS One. 2012;7(9):e46001. doi: 10.1371/journal.pone.0046001.

8.

SIRT1 regulates endothelial Notch signaling in lung cancer.

Xie M, Liu M, He CS.

PLoS One. 2012;7(9):e45331. doi: 10.1371/journal.pone.0045331. Erratum in: PLoS One. 2013;8(4). doi: 10.1371/annotation/d8a41471-71e5-45a2-bb57-5f565258142f. PLoS One. 2013;8(4). doi:10.1371/annotation/b81b3c0e-108e-479e-b2cf-91aa92623495.

9.

Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Chen S, Sang N.

J Biomed Biotechnol. 2011;2011:197946. doi: 10.1155/2011/197946. Review.

10.

Krüppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs.

Zhang R, Han M, Zheng B, Li YJ, Shu YN, Wen JK.

Acta Pharmacol Sin. 2010 Oct;31(10):1293-302. doi: 10.1038/aps.2010.96.

11.

A novel Pzg-NURF complex regulates Notch target gene activity.

Kugler SJ, Nagel AC.

Mol Biol Cell. 2010 Oct 1;21(19):3443-8. doi: 10.1091/mbc.E10-03-0212.

12.

Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains.

Reynoird N, Schwartz BE, Delvecchio M, Sadoul K, Meyers D, Mukherjee C, Caron C, Kimura H, Rousseaux S, Cole PA, Panne D, French CA, Khochbin S.

EMBO J. 2010 Sep 1;29(17):2943-52. doi: 10.1038/emboj.2010.176.

13.

GSK3beta is a negative regulator of the transcriptional coactivator MAML1.

Saint Just Ribeiro M, Hansson ML, Lindberg MJ, Popko-Scibor AE, Wallberg AE.

Nucleic Acids Res. 2009 Nov;37(20):6691-700. doi: 10.1093/nar/gkp724.

Supplemental Content

Support Center